The evolving treatment of diabetic retinopathy
SE Mansour, DJ Browning, K Wong… - Clinical …, 2020 - Taylor & Francis
Purpose To review the current therapeutic options for the management of diabetic
retinopathy (DR) and diabetic macular edema (DME) and examine the evidence for …
retinopathy (DR) and diabetic macular edema (DME) and examine the evidence for …
Treatment of diabetic macular edema
EJ Kim, WV Lin, SM Rodriguez, A Chen, A Loya… - Current diabetes …, 2019 - Springer
Abstract Purpose of Review Diabetes mellitus is a global epidemic which is growing in
prevalence, and diabetic macular edema (DME) is a leading cause of visual impairment …
prevalence, and diabetic macular edema (DME) is a leading cause of visual impairment …
[HTML][HTML] Ranibizumab induces regression of diabetic retinopathy in most patients at high risk of progression to proliferative diabetic retinopathy
Purpose To evaluate diabetic retinopathy (DR) outcomes with ranibizumab (Lucentis,
Genentech, Inc., South San Francisco, CA) treatment in patients with DR and diabetic …
Genentech, Inc., South San Francisco, CA) treatment in patients with DR and diabetic …
[HTML][HTML] New insights in resistant diabetic macular edema
Diabetic macular edema (DME) is the most common cause of vision loss in diabetic eyes,
and due to the rapid rise in the number of diabetic patients, the treatment burden has …
and due to the rapid rise in the number of diabetic patients, the treatment burden has …
Diabetic macular edema
GE Lang - Ophthalmologica, 2012 - karger.com
Diabetic retinopathy is one of the major complications of diabetes mellitus and a leading
cause of visual loss. Diabetic macular edema (DME) is an ocular manifestation of the …
cause of visual loss. Diabetic macular edema (DME) is an ocular manifestation of the …
Characteristics of diabetic macular edema patients refractory to anti-VEGF treatments and a dexamethasone implant
Purpose To determine the characteristics of diabetic macular edema (DME) patients
refractory to intravitreal bevacizumab (IVB) treatments and an additional dexamethasone …
refractory to intravitreal bevacizumab (IVB) treatments and an additional dexamethasone …
Adipose stem cells and their paracrine factors are therapeutic for early retinal complications of diabetes in the Ins2Akita mouse
Background Early-stage diabetic retinopathy (DR) is characterized by neurovascular
defects. In this study, we hypothesized that human adipose-derived stem cells (ASCs) …
defects. In this study, we hypothesized that human adipose-derived stem cells (ASCs) …
Distinctive mechanisms and patterns of exudative versus tractional intraretinal cystoid spaces as seen with multimodal imaging
Purpose To determine clear-cut distinctions between tractional and exudative intraretinal
cystoid spaces subtypes. Design Retrospective, multicenter, observational case series …
cystoid spaces subtypes. Design Retrospective, multicenter, observational case series …
[HTML][HTML] Diabetic macular edema treatment guidelines in India: All India ophthalmological society diabetic retinopathy task force and vitreoretinal society of India …
S Giridhar, L Verma, A Rajendran… - Indian Journal of …, 2021 - journals.lww.com
Diabetic macular edema (DME) is a common cause of moderate visual impairment among
people with diabetes. Due to the rising number of people with diabetes in India, the absolute …
people with diabetes. Due to the rising number of people with diabetes in India, the absolute …
Vitrectomy for diabetic macular edema: optical coherence tomography criteria and pathology of the vitreomacular interface
F Hagenau, D Vogt, J Ziada, SR Guenther… - American Journal of …, 2019 - Elsevier
Purpose To correlate spectral-domain optical coherence tomography (SDOCT) criteria and
clinical data with pathology of the vitreomacular interface (VMI) in eyes with diabetic macular …
clinical data with pathology of the vitreomacular interface (VMI) in eyes with diabetic macular …